RAYONIER ADVANCED MATERIALS (RYAM)
US75508B1044 - Common Stock
RYAM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. RYAM has a bad profitability rating. Also its financial health evaluation is rather negative. RYAM has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year RYAM has reported negative net income.
RYAM had a positive operating cash flow in the past year.
In multiple years RYAM reported negative net income over the last 5 years.
In the past 5 years RYAM always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of -4.67%, RYAM is doing worse than 77.38% of the companies in the same industry.
The Return On Equity of RYAM (-13.65%) is worse than 79.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.67% | ||
| ROE | -13.65% | ||
| ROIC | N/A |
ROA(3y)-0.86%
ROA(5y)-0.76%
ROE(3y)-2.43%
ROE(5y)-2.35%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RYAM's Operating Margin has declined in the last couple of years.
The Gross Margin of RYAM (5.36%) is worse than 86.90% of its industry peers.
RYAM's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for RYAM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 5.36% |
OM growth 3YN/A
OM growth 5Y-42.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.37%
GM growth 5Y-16.92%
2. Health
2.1 Basic Checks
RYAM does not have a ROIC to compare to the WACC, probably because it is not profitable.
RYAM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, RYAM has more shares outstanding
Compared to 1 year ago, RYAM has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.21, we must say that RYAM is in the distress zone and has some risk of bankruptcy.
RYAM's Altman-Z score of 1.21 is on the low side compared to the rest of the industry. RYAM is outperformed by 71.43% of its industry peers.
RYAM has a debt to FCF ratio of 90.36. This is a negative value and a sign of low solvency as RYAM would need 90.36 years to pay back of all of its debts.
RYAM's Debt to FCF ratio of 90.36 is in line compared to the rest of the industry. RYAM outperforms 40.48% of its industry peers.
RYAM has a Debt/Equity ratio of 1.01. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.01, RYAM is doing worse than 67.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.01 | ||
| Debt/FCF | 90.36 | ||
| Altman-Z | 1.21 |
ROIC/WACCN/A
WACC7.67%
2.3 Liquidity
RYAM has a Current Ratio of 1.53. This is a normal value and indicates that RYAM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of RYAM (1.53) is worse than 73.81% of its industry peers.
RYAM has a Quick Ratio of 1.53. This is a bad value and indicates that RYAM is not financially healthy enough and could expect problems in meeting its short term obligations.
RYAM has a worse Quick ratio (0.98) than 69.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
RYAM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -904.00%.
The Revenue has decreased by -4.30% in the past year.
Measured over the past years, RYAM shows a decrease in Revenue. The Revenue has been decreasing by -3.43% on average per year.
EPS 1Y (TTM)-904%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-3860%
Revenue 1Y (TTM)-4.3%
Revenue growth 3Y6.94%
Revenue growth 5Y-3.43%
Revenue growth Q2Q-15.5%
3.2 Future
RYAM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 43.37% yearly.
The Revenue is expected to grow by 3.89% on average over the next years.
EPS Next Y83.61%
EPS Next 2Y43.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3%
Revenue Next 2Y3.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
RYAM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RYAM. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, RYAM is valued cheaply inside the industry as 82.14% of the companies are valued more expensively.
RYAM's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.32 | ||
| EV/EBITDA | 6.9 |
4.3 Compensation for Growth
RYAM's earnings are expected to grow with 43.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.37%
EPS Next 3YN/A
5. Dividend
5.1 Amount
RYAM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
RAYONIER ADVANCED MATERIALS
NYSE:RYAM (5/3/2024, 7:16:47 PM)
After market: 3.98 0 (0%)3.98
+0.03 (+0.76%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap260.85M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.67% | ||
| ROE | -13.65% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 5.36% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.01 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-904%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y83.61%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.3%
Revenue growth 3Y6.94%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y